Thiotepa and Micafungin sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Thiotepa (thiotepa) and Micafungin sodium (micafungin sodium). Common drug interactions include encephalitis viral among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Thiotepa and Micafungin sodium. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Thiotepa?

Thiotepa has active ingredients of thiotepa. eHealthMe is studying from 8,097 Thiotepa users. Check the latest studies of Thiotepa.

What is Micafungin sodium?

Micafungin sodium has active ingredients of micafungin sodium. eHealthMe is studying from 1,787 Micafungin sodium users. Check the latest studies of Micafungin sodium.



On Jul, 30, 2026

21 people who take Thiotepa and Micafungin sodium together, and have interactions are studied.

Thiotepa and Micafungin sodium drug interactions.

What are the common drug interactions of Thiotepa and Micafungin Sodium, by gender? *:

female:

  1. Encephalitis viral (inflammation of the brain due to viral infection)
  2. Human herpesvirus 6 infection
  3. Bacterial sepsis
  4. Meningoencephalitis herpetic (inflammation of the brain and meninges by virus)
  5. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  6. Epstein-barr virus infection
  7. Skin exfoliation (removal of the oldest dead skin cells)
  8. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  9. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  10. Acute respiratory failure

male:

  1. Diarrhoea
  2. Pyrexia (fever)
  3. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  4. Confusional state
  5. General physical health deterioration (weak health status)
  6. Haematemesis (vomiting of blood)
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  8. Hallucination (an experience involving the perception of something not present)
  9. Hyperbilirubinaemia (excess of bilirubin in the blood)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Thiotepa and Micafungin Sodium, by age (0-1 to 60+)? *:

0-1:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Hepatic failure (liver failure)
  3. Hepatotoxicity (chemical-driven liver damage)

2-9:

  1. Encephalitis viral (inflammation of the brain due to viral infection)
  2. Human herpesvirus 6 infection
  3. Bacterial sepsis
  4. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  5. Epstein-barr virus infection
  6. Meningoencephalitis herpetic (inflammation of the brain and meninges by virus)
  7. Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
  8. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  9. Chronic graft versus host disease (immune cells attack the host's body cells after transplant)

10-19:

  1. Diarrhoea
  2. Myelosuppression (a decrease in the production of blood cells)
  3. Pyrexia (fever)
  4. Encephalitis viral (inflammation of the brain due to viral infection)
  5. Eosinophil count increased
  6. Human herpesvirus 6 infection
  7. Platelet count decreased
  8. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  9. Meningoencephalitis herpetic (inflammation of the brain and meninges by virus)
  10. Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)

20-29:

n/a

30-39:

  1. Haematemesis (vomiting of blood)
  2. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  3. Hallucination (an experience involving the perception of something not present)
  4. Hyperbilirubinaemia (excess of bilirubin in the blood)
  5. Hypotension (abnormally low blood pressure)
  6. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  7. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  8. Mucosal inflammation (infection of mucous membrane)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Renal failure acute (rapid kidney dysfunction)

40-49:

  1. Skin exfoliation (removal of the oldest dead skin cells)
  2. Acute respiratory failure
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Cytomegalovirus enterocolitis (virus infection of intestine and colon)
  5. Gastrointestinal mucosal disorder (disorder of gastrointestinal lining mucous membranes)
  6. Herpes zoster
  7. Venoocclusive liver disease (small veins in the liver are obstructed)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 5 people, 23.81%
  2. Medulloblastoma (a fast-growing, high-grade tumour that always begins in the cerebellum): 4 people, 19.05%
  3. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 19.05%
  4. Neuroblastoma (a cancer that forms in your nerve tissue): 2 people, 9.52%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Thiotepa and Micafungin sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Thiotepa and Micafungin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Thiotepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micafungin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thiotepa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micafungin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on thiotepa and micafungin sodium (the active ingredients of Thiotepa and Micafungin sodium, respectively), and Thiotepa and Micafungin sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: